Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets
- PMID: 23409771
- DOI: 10.3109/0284186X.2012.752860
Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets
Abstract
Internal target and organ motion during treatment is a challenge in radiotherapy (RT) of the prostate and the involved elective targets, with residual motion being present also following image-guidance strategies. The aim of this study was to investigate organ motion-induced dose degradations for the prostate, seminal vesicle and the pelvic lymph node when treating these targets with proton therapy, using different image-guidance and delivery strategies.
Material and methods: Four patients were selected from a larger series as they displayed large inter-fractional variation in bladder and rectum volume. Intensity-modulated proton therapy plans were generated using both simultaneous integrated and sequential boost delivery. For each technique, three isotropic margin expansions (in the range of 4-10 mm) were evaluated for the clinical target volume of prostate (CTV-p), seminal vesicles (CTV-sv) and lymph nodes (CTV-ln). Simulation of the dose degradations for all treatment plans were based on dose re-calculations for the 8-9 repeat CTs available for each patient, after applying rigid registrations to reproduce set-up based on either intra-prostatic fiducials or bony anatomy.
Results: The simulated dose received by 99% of the target volume (D(99)) and generalized equivalent dose (gEUD) showed substantial inter-patient variations. For 40% of the investigated scenarios, the patient average simulated D(99) for all targets were within 2 GyE from the planned dose. The largest difference between simulated and planned dose was seen for the CTV-sv when using SIB delivery, with an average relative reduction in D(99) of 13% and 15% for the largest margin expansion, when positioned using fiducials and bony anatomy, respectively.
Conclusions: The most severe dose degradations were found for CTV-sv, but they were also evident for CTV-ln. The degradations could not be completely resolved, neither by using the largest margin expansion nor with the choice of set-up. With fiducial set-up CTV-p was robust against the inter-fraction changes.
Similar articles
-
Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1254-60. doi: 10.1016/j.ijrobp.2009.04.034. Int J Radiat Oncol Biol Phys. 2009. PMID: 19857789
-
Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.Acta Oncol. 2011 Aug;50(6):926-34. doi: 10.3109/0284186X.2011.590522. Acta Oncol. 2011. PMID: 21767193
-
Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1186-94. doi: 10.1016/j.ijrobp.2014.08.015. Epub 2014 Oct 13. Int J Radiat Oncol Biol Phys. 2014. PMID: 25442043
-
Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1455-62. doi: 10.1016/j.ijrobp.2011.12.058. Epub 2012 Mar 6. Int J Radiat Oncol Biol Phys. 2012. PMID: 22401917
-
Robust radiotherapy planning.Phys Med Biol. 2018 Nov 12;63(22):22TR02. doi: 10.1088/1361-6560/aae659. Phys Med Biol. 2018. PMID: 30418942 Review.
Cited by
-
Proton therapy- the modality of choice for future radiation therapy management of Prostate Cancer?Tech Innov Patient Support Radiat Oncol. 2019 Oct 11;11:1-13. doi: 10.1016/j.tipsro.2019.08.001. eCollection 2019 Sep. Tech Innov Patient Support Radiat Oncol. 2019. PMID: 32095544 Free PMC article. Review.
-
Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.Radiat Oncol. 2016 Mar 12;11:39. doi: 10.1186/s13014-016-0612-z. Radiat Oncol. 2016. PMID: 26968827 Free PMC article.
-
Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.Sci Rep. 2023 May 8;13(1):7448. doi: 10.1038/s41598-023-34339-w. Sci Rep. 2023. PMID: 37156901 Free PMC article.
-
Evaluation of an a priori scatter correction algorithm for cone-beam computed tomography based range and dose calculations in proton therapy.Phys Imaging Radiat Oncol. 2020 Oct 27;16:89-94. doi: 10.1016/j.phro.2020.09.014. eCollection 2020 Oct. Phys Imaging Radiat Oncol. 2020. PMID: 33458349 Free PMC article.
-
A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy.Acta Oncol. 2017 Jun;56(6):799-805. doi: 10.1080/0284186X.2017.1300684. Epub 2017 Mar 15. Acta Oncol. 2017. PMID: 28293971 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials